Phibro Animal Health Corporation Financials

Market Capitalization $1.13 Billion as of July 1, 2025

Valuations Metrics as of May. 5, 2024

Trailing PE	45.35
Forward PE	13.64
Price to Sales TTM	$0.69
Price to Book MRQ	$2.51
Enterprise to Revenue	1.11
Enterprise to EBITDA	11.96

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends	2023-06-30
Most Recent Quarter	2023-12-31
Profit Margin	1.51%
Operating Margin	6.41%
Return on Assets TTM	3.72%
Return on Equity TTM	5.49%

Income Statement

Revenue TTM	$982,014,016
Revenue per Share TTM	$24.25
Quarterly Revenue Growth	2.20%
Gross Profit TTM	$298,237,000
EBITDA	$95,224,000
Net Income to Common TTM	$14,799,000
Diluted EPS TTM	$0.37
Quarterly Earnings Growth YoY	-82.30%

Balance Sheet

Total Cash MRQ	$104,842,000
Total Cash per Share MRQ	$2.59
Total Debt MRQ	$
Total Debt to Equity MRQ	189.47
Current Ratio MRQ	3.13
Book Value per Share MRQ	$6.69

Cash Flow

Operating Cash Flow TTM	$74,254,000
Levered Free Cash Flow TTM	$38,287,876

PAHC Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding	20,337,600
Float Shares	20,212,110
Avg 10 Volume	174,110
Avg 30 Volume	None
Shares Short	626,542
Short Ratio	4.82
Short % of Shares	5.15%
% Held by Insiders	0.63%
% Held by Institutions	103.52%

Stock Price Summary

Beta	0.74
Fifty Two Week Low	$9.40
Fifty Two Week High	$17.20
Fifty Two Week Change	15.82%
Day 50 MA	$12.91
Day 200 MA	$12.48

Dividends and Splits

Forward Annual Dividend Rate	$0.48
Forward Annual Dividend Yield	2.81%
Trailing Annual Dividend Rate	$0.48
Trailing Annual Dividend Yield	2.81%
Payout Ratio	129.73%
Dividend Date	2024-03-27
Ex Dividend Date	2024-03-05
Last Split Factor
Last Split Date